AVMA asks FDA to extend comment period on animal drug compounding

This week, the AVMA submitted a letter asking the U.S. Food and Drug Administration (FDA) to clarify its latest proposal to regulate animal drug compounding from bulk substances and allow at least a 120-day extension for commenting on the proposal.